James C. Czirr - 22 Apr 2024 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role: 10%+ Owner
Signature: /s/ James C. Czirr, Individually
Issuer symbol: GALT
Transactions as of: 22 Apr 2024
Net transactions value: -$76,500
Form type: 4
Filing time: 25 Apr 2024, 11:36:44 UTC
Previous filing: 25 Apr 2024
Next filing: 11 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GALT	Common Stock	Sale	$65,248	-21,323	-0.36%	$3.06	5,925,884	22 Apr 2024	By 10X Fund, LP	F1
transaction	GALT	Common Stock	Sale	$11,252	-3,677	-0.06%	$3.06	5,922,207	23 Apr 2024	By 10X Fund, LP	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities were sold by 10X Fund, LP. James C. Czirr is the manager of 10X Capital Management, LLC, which is the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such Mr. Czirr may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Content

The securities were sold by 10X Fund, LP. James C. Czirr is the manager of 10X Capital Management, LLC, which is the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such Mr. Czirr may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.